4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and Learning Disabilities

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with Learning Disabilities in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balducci, C; Bonalumi, P; Carli, M; Millan, MJ; Samanin, R	1

Other Studies

1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and Learning Disabilities

Article	Year
S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. British journal of pharmacology, 1999, Volume: 128, Issue:6 Topics: Animals; Hippocampus; Learning Disabilities; Male; Maze Learning; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses; Time Factors	1999

Article

Year

S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

British journal of pharmacology, 1999, Volume: 128, Issue:6

Topics: Animals; Hippocampus; Learning Disabilities; Male; Maze Learning; Piperazines; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Scopolamine; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses; Time Factors

1999